FDA Approved: ENOXAPARIN SODIUM — Supplemental Application (Sanofi-Aventis U.S. LLC)

View source ↗

Summary

FDA approves a Supplemental Application for enoxaparin sodium from Sanofi-Aventis U.S. LLC to update the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Deep Vein Thrombosis
• Myocardial Infarction
• Pulmonary Embolism

Drugs mentioned

• Enoxaparin sodium (Enoxaparin sodium)

Snippet

SUPPL AP for ENOXAPARIN SODIUM (ENOXAPARIN SODIUM)